Our Company

two women in lab - who we are

Who We Are

We are a world-class team of scientists, drug developers, and manufacturing experts who are united in our shared goal of finding in vivo solutions to fulfill the promise of CAR T cell therapies for every patient in need. 

Leadership

Sally Dyer
SVP, General Manager, Colorado Operations
She/Her/Hers
Branden Salinas
Executive Director, Process & Product Development
He/Him/His

Board of Directors

Chairman of the Board
Co-founder & Chief Executive Officer
MPM Capital
DCVC Bio
Qiming Venture Partners USA
SoftBank
Co-founder & Managing Partner, Double Point Ventures

Scientific Advisory Board

Purdue University, Co-founder, Umoja Biopharma, Scientific Advisory Board Co-chair
Seattle Children's Hospital, Co-founder, Umoja Biopharma, Scientific Advisory Board Co-chair
Fred Hutch Endowed Chair for Cell and Gene Therapy
Ben Towne Center for Childhood Cancer
Henry Pitot Professor of Pathology & Laboratory Medicine, University of Wisconsin, Madison

Current Investors

DCVC Bio
Casdin Capital
CORMORANT ASSET MANAGEMENT
EMERSON COLLECTIVE
Qiming Venture Partners
MPM
Presight Capital
RTW Investments
SoftBank Group
Temasek

Together, we are advancing in vivo CAR T cell therapies to fulfill the promise of this treatment option to every patient in need. Learn more about our team of experts.